Results 101 to 110 of about 340,355 (361)

Comparison of endoscopic findings in Egyptian and Indian patients: a retrospective cohort

open access: yesAl-Azhar Assiut Medical Journal, 2019
Aims Esophagogastroduodenoscopy is the commonest diagnostic procedure performed to evaluate upper gastrointestinal tract. However, there are limited data on the differences in endoscopic findings in different populations.
Essam A Hassan   +2 more
doaj   +1 more source

Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma

open access: yesDigestive Diseases and Sciences, 2016
Esophageal adenocarcinoma and its precursor Barrett’s esophagus have been rapidly increasing in incidence for half a century, for reasons not adequately explained by currently identified risk factors such as gastroesophageal reflux disease and obesity ...
Erik J. Snider, D. Freedberg, J. Abrams
semanticscholar   +1 more source

Tumor‐Derived LAMB3 Drives Immunosuppressive LRRC15+ Fibroblast Formation During Pancreatic Ductal Adenocarcinoma Development

open access: yesAdvanced Science, EarlyView.
A single‐cell atlas of pancreatic ductal adenocarcinoma development reveals progressive ductal‐fibroblast‐immune crosstalk. Tumor‐derived LAMB3 drives the formation of immunosuppressive LRRC15+ fibroblasts through the ITGB1/FAK/MAPK/FOSL2 signaling. Glycolytic reprogramming upregulates LAMB3 and correlates with LRRC15+ fibroblast enrichment.
Xuqing Shi   +23 more
wiley   +1 more source

In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma

open access: yes, 2014
Human epidermal growth factor receptor 2 (HER2) is involved in the malignant progression of several human cancers, including esophageal adenocarcinoma (EAC).
H. Zhang   +13 more
core   +1 more source

Esophagus: Barrett's esophagus, dysplasia and adenocarcinoma [PDF]

open access: yes, 2010
Review on Esophagus: Barrett's esophagus, dysplasia and adenocarcinoma, with data on clinics, and the genes ...
D Peng, El-Rifai, W, Peng, D, W El-Rifai
core   +1 more source

Cuproptosis and Mitophagy Mediated by the THUMPD1/IGF2R‐Dependent Suppression of AKT and Activation of AMPK Signaling Suppress Lung Adenocarcinoma Progression

open access: yesAdvanced Science, EarlyView.
THUMPD1 drives a tumor‐suppressive signaling cascade in lung adenocarcinoma by promoting IGF2R expression. IGF2R associates with PPP2R1A to suppress AKT and activate AMPK, leading to SLC31A1 upregulation and copper accumulation. Elevated copper disrupts mitochondrial metabolism and induces excessive mitophagy, thereby restraining tumor growth and ...
Kai Wu   +10 more
wiley   +1 more source

Development and Stem Cells of the Esophagus

open access: yesSeminars in Cell and Developmental Biology, 2016
The esophagus is derived from the anterior portion of the developmental intermediate foregut, a structure that also gives rise to other organs including the trachea, lung, and stomach. Genetic studies have shown that multiple signaling pathways (e.g. Bmp)
Yongchun Zhang   +6 more
semanticscholar   +1 more source

Surgical repair of Type II-IV Hiatal Hernia: frequency of True Short Esophagus and Results.

open access: yes, 2012
Background: The surgical management of type II-IV hiatal hernia is controversial. Failure to recognize the condition of short esophagus may concur to the high rate of hernia’s recurrence.
MATTIOLI, SANDRO   +4 more
core  

Squamous cell carcinoma in Barrett’s esophagus: field effect versus metastasis

open access: yes, 2012
Barrett’s esophagus (BE) is a premalignant condition with an increased risk of developing esophageal adenocarcinoma (EAC). Risk factors for EAC overlap with those for esophageal squamous cell carcinoma (ESCC), but ESCC is surprisingly rare in BE.
Siersema, P. D.   +7 more
core   +1 more source

Impact of Radiotherapy, Chemotherapy and Surgery in Multimodal Treatment of Locally Advanced Esophageal Cancer [PDF]

open access: yes, 2011
Objectives: It was the aim of this study to assess our institutional experience with definitive chemoradiation (CRT) versus induction chemotherapy followed by CRT with or without surgery (C-CRT/S) in esophageal cancer.
Annina Lemminger   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy